SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea ...
ResMed RMD has introduced AirFit N30, which is the first tube-down nasal cradle continuous positive airway pressure (“CPAP”) mask, with a front-facing tube. This will present the latest treatment ...
SCOTTSDALE, AZ / ACCESSWIRE / November 5, 2014 / AirWare Labs Corp. (AIRW) today announced the filing of a new patent application for a cutting-edge CPAP (Continuous Positive Airway Pressure) ...
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea treatment. This press ...
ResMed (NYSE:RMD) has introduced AirFit N30, which is the first tube-down nasal cradle continuous positive airway pressure (“CPAP”) mask, with a front-facing tube. This will present the latest ...
ResMed is releasing a new nasal cradle CPAP mask that features a front-facing tube that points downward. The AirFit N30 mask is the first of its kind, as similar masks typically have the air tube ...
Sorry, your browser doesn't support embedded videos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback